In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.12 in the last session, down -0.88% from day before closing price of $1.13. In other words, the price has decreased by -$0.88 from its previous closing price. On the day, 3.28 million shares were traded. ALLO stock price reached its highest trading level at $1.18 during the session, while it also had its lowest trading level at $1.12.
Ratios:
We take a closer look at ALLO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.92 and its Current Ratio is at 8.92. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when MESSEMER DEBORAH M. sold 36,885 shares for $1.42 per share. The transaction valued at 52,377 led to the insider holds 107,431 shares of the business.
MESSEMER DEBORAH M. bought 36,885 shares of ALLO for $52,391 on Jun 10 ’25. On Apr 21 ’25, another insider, Yoshiyama Annie, who serves as the SVP, Finance of the company, sold 9,601 shares for $1.41 each. As a result, the insider received 13,537 and left with 130,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 248506720 and an Enterprise Value of 64602564.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.36, which has changed by -0.5658915 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -6.81%, while the 200-Day Moving Average is calculated to be -30.74%.
Shares Statistics:
According to the various share statistics, ALLO traded on average about 4.02M shares per day over the past 3-months and 3870570 shares per day over the past 10 days. A total of 220.13M shares are outstanding, with a floating share count of 151.97M. Insiders hold about 31.51% of the company’s shares, while institutions hold 60.52% stake in the company. Shares short for ALLO as of 1755216000 were 24472217 with a Short Ratio of 6.09, compared to 1752537600 on 25930643. Therefore, it implies a Short% of Shares Outstanding of 24472217 and a Short% of Float of 13.309999999999999.
Earnings Estimates
The stock of Allogene Therapeutics Inc (ALLO) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.15 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.89 and -$1.2 for the fiscal current year, implying an average EPS of -$1.02. EPS for the following year is -$0.98, with 10.0 analysts recommending between -$0.55 and -$1.47.
